5-azacitidine
Showing 1 - 11 of 11
Lymphoma, T-Cell Trial in Charlottesville (Durvalumab, Pralatrexate, Romidepsin)
Recruiting
- Lymphoma, T-Cell
- Durvalumab
- +3 more
-
Charlottesville, VirginiaUniversity of Virginia
Mar 16, 2022
Prostatic Tumors, Prostate Tumors, Prostate Cancer Trial in New York (5-Azacitidine, all trans retinoic acid, Lupron)
Completed
- Prostatic Neoplasms
- +2 more
- 5-Azacitidine
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Aug 1, 2022
Myelodysplastic Syndromes and Acute Myeloid Leukemia
Withdrawn
- Myelodysplastic Syndromes
- Acute Myeloid Leukemia
- 5-azacitidine
-
Huixquilucan, Estado De México, MexicoGrupo Cooperativo de Hemopatías Malignas
Jul 5, 2021
Acute Myeloid Leukemia Trial in La Jolla, Stanford, Atlanta (5-Azacitidine, Gemtuzumab ozogamicin)
Completed
- Acute Myeloid Leukemia
- 5-Azacitidine
- Gemtuzumab ozogamicin
-
La Jolla, California
- +2 more
Jan 31, 2019
Leukemia Trial in Houston (Pacritinib, 5-azacitidine, Decitabine)
Terminated
- Leukemia
- Pacritinib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 18, 2018
Chronic Myelomonocytic Leukemia Trial in Buffalo, Portland, Salt Lake City (5-Azacitidine)
Completed
- Chronic Myelomonocytic Leukemia
- 5-Azacitidine
-
Buffalo, New York
- +2 more
May 10, 2016
Leukemia Trial in Tampa (5-azacitidine, Allogeneic Hematopoietic Cell Transplantation (HCT))
Completed
- Leukemia
- 5-azacitidine
- Allogeneic Hematopoietic Cell Transplantation (HCT)
-
Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
Sep 11, 2014
Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Germany (5-Azacitidine)
Completed
- Myelodysplastic Syndrome
- Acute Myeloid Leukemia
- 5-Azacitidine
-
Heidelberg, Baden-Wuertemberg, Germany
- +5 more
Jan 20, 2012